PPT-Immune Thrombocytopenia Disease Awareness Program Slide

Novartis Singapore P3 approval SG2010199741 Exp 18Oct2022 Disclaimer This presentationslide deck may include data on an indication that has not been approved or cleared for use in Singapore by the Health Sciences Authority It is intended to provide you with pertinent scientific data to form your own conclusions and make your own decisions Information in this presentationslide deck is not intended to be promoting or recommending any indication dosage or other claim not covered in the licensed product information Novartis does not support the promotion of its products in a manner inconsistent with its approved labelling. The immune mediated form can lead to thrombo sis and the need to consider alternative therapies Types of hepari n related thrombocytopenia HAT Non immune Mediated HIT Immune Mediated Frequency 10 30 1 3 Timing of Onset 4 days Typical 5 10 days Acute Chapter 40. Agents of Disease. The human body provides a suitable environment for many microorganisms: it is moist, warm and full of nutrients.. Not all microorganisms are harmful; some are beneficial. Joanna Rupa-Matysek. Hemostatic. System - . general. . information. Normal . hemostatic. system . vessel wall. circulating blood platelets. blood coagulation and . fibrynolysis. Bleeding. . Diathesis. Platelet Counts. Vary with . Age (slight decrease in mean with increased age). Sex (Slightly lower mean in men). Consequences of Misdiagnosis of Inherited Thrombocytopenia. Wrong therapy. Wrong prognosis. (HIT). HEPARIN-INDUCED THROMBOCYTOPENIA. Unfractionated heparin (UFH) (beef > pork). Continuous iv infusion. Cardiopulmonary bypass. Low dose sq. Heparin flushes. Heparin-bonded catheters. Low molecular weight heparin. Articles. by . Ryan Burris, Ali Naqvi, Wendy Yang. Presentation. by . Sam . Lai, Alex . Raufi. Questions. by . Vicki Cheng. Definition. Mild: 100 to 150. Moderate. : 50 to 100. Severe. : < 50. Keep in mind, these are 95% confidence intervals, so 2.5% of population < 150. Michael Dougan, MD, PhD. Director of the Immunotherapy Mucosal Toxicities Program. Massachusetts General Hospital. 21 March 2018. Cancer is like an infection that can’t be cleared. Mutations can be recognized. limba. . engleza. 2012-2013. Background. 1/3 of all Hematology Consults in a General Hospital are for . thrombocytopenia. 5 to 10% of all hospital patients are thrombocytopenic in the ICU the number increases to 35. purpura. (ITP). Immune thrombocytopenia . purpura. (ITP). 1- Chronic ITP: . This is relatively common disorder ,with highest incidence in . women. . 15-50 y. ,it is commonest cause of thrombocytopenia without anemia or neutropenia ,it is usually . 30 September 2019 Pharmaceuticals Creating a global growth platform in haematology In order to utilise the ‘Safe Harbor’ provisions of the United States Private Securities Litigation Reform Ac Idiopathic Thrombocytopenic PurpuraJune 26 2019May 2019Thrombocytopenia May 21 2018May 2019 2 Drug InformationRegulatory InformationManufacturerDova PharmaceuticalsApplication TypeSupplemental NDAD in a young girl. Dr.Manoj. . Prakash.J. JR-II. Dept. of Medicine. HISTORY. A 16 Yrs old female patient came to . casulty. . c/o . massive Per vaginal bleeding since 15 days. . She also complained of giddiness and breathlessness on . Charlotte A. Bradbury. , . Julie . Pell. Published in . nejm. on 02 . sep. 2021 . INTRODUCTION . Immune thrombocytopenia is a . rare condition. , with an incidence . in . . adults . of . 2.9 per . . jithin. P JR1 Medicine. introduction. P. latelets. are one of the blood cells that are released from megakaryocytes.